These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis. Lands LC; Stanojevic S Cochrane Database Syst Rev; 2016 Apr; 4():CD001505. PubMed ID: 27055154 [TBL] [Abstract][Full Text] [Related]
3. Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis. Stotland PK; Radzioch D; Stevenson MM Pediatr Pulmonol; 2000 Nov; 30(5):413-24. PubMed ID: 11064433 [TBL] [Abstract][Full Text] [Related]
4. Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis. Lands LC; Stanojevic S Cochrane Database Syst Rev; 2013 Jun; (6):CD001505. PubMed ID: 23765216 [TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory medications for cystic fibrosis lung disease: selecting the most appropriate agent. Chmiel JF; Konstan MW Treat Respir Med; 2005; 4(4):255-73. PubMed ID: 16086599 [TBL] [Abstract][Full Text] [Related]
6. High-dose ibuprofen therapy associated with esophageal ulceration after pneumonectomy in a patient with cystic fibrosis: a case report. Mackey JE; Anbar RD BMC Pediatr; 2004 Sep; 4():19. PubMed ID: 15363106 [TBL] [Abstract][Full Text] [Related]
7. The role of inflammation in the pathophysiology of CF lung disease. Chmiel JF; Berger M; Konstan MW Clin Rev Allergy Immunol; 2002 Aug; 23(1):5-27. PubMed ID: 12162106 [TBL] [Abstract][Full Text] [Related]
8. Oral non-steroidal anti-inflammatory drug therapy for cystic fibrosis. Lands LC; Stanojevic S Cochrane Database Syst Rev; 2007 Oct; (4):CD001505. PubMed ID: 17943753 [TBL] [Abstract][Full Text] [Related]
9. Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill. Boucher RC; Knowles MR; Johnson LG; Olsen JC; Pickles R; Wilson JM; Engelhardt J; Yang Y; Grossman M Hum Gene Ther; 1994 May; 5(5):615-39. PubMed ID: 7519885 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological approaches for the discovery and development of new anti-inflammatory agents for the treatment of cystic fibrosis. Konstan MW; Davis PB Adv Drug Deliv Rev; 2002 Dec; 54(11):1409-23. PubMed ID: 12458152 [TBL] [Abstract][Full Text] [Related]
12. Ibuprofen attenuates the inflammatory response to Pseudomonas aeruginosa in a rat model of chronic pulmonary infection. Implications for antiinflammatory therapy in cystic fibrosis. Konstan MW; Vargo KM; Davis PB Am Rev Respir Dis; 1990 Jan; 141(1):186-92. PubMed ID: 2153353 [TBL] [Abstract][Full Text] [Related]
13. Progression of Cystic Fibrosis Lung Disease from Childhood to Adulthood: Neutrophils, Neutrophil Extracellular Trap (NET) Formation, and NET Degradation. Khan MA; Ali ZS; Sweezey N; Grasemann H; Palaniyar N Genes (Basel); 2019 Feb; 10(3):. PubMed ID: 30813645 [TBL] [Abstract][Full Text] [Related]
14. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772 [TBL] [Abstract][Full Text] [Related]
15. Digitoxin for Airway Inflammation in Cystic Fibrosis: Preliminary Assessment of Safety, Pharmacokinetics, and Dose Finding. Zeitlin PL; Diener-West M; Callahan KA; Lee S; Talbot CC; Pollard B; Boyle MP; Lechtzin N Ann Am Thorac Soc; 2017 Feb; 14(2):220-229. PubMed ID: 28006108 [TBL] [Abstract][Full Text] [Related]
16. Nonsteroidal anti-inflammatory drugs upregulate function of wild-type and mutant CFTR. Li J; Xiang YY; Ye L; Tsui LC; Macdonald JF; Hu J; Lu WY Eur Respir J; 2008 Aug; 32(2):334-43. PubMed ID: 18385167 [TBL] [Abstract][Full Text] [Related]
17. New and emerging therapies for pulmonary complications of cystic fibrosis. Tonelli MR; Aitken ML Drugs; 2001; 61(10):1379-85. PubMed ID: 11558827 [TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatories and mucociliary clearance therapies in the age of CFTR modulators. Perrem L; Ratjen F Pediatr Pulmonol; 2019 Nov; 54 Suppl 3():S46-S55. PubMed ID: 31715088 [TBL] [Abstract][Full Text] [Related]
19. Leukotriene receptor antagonists in children with cystic fibrosis lung disease : anti-inflammatory and clinical effects. Schmitt-Grohé S; Zielen S Paediatr Drugs; 2005; 7(6):353-63. PubMed ID: 16356023 [TBL] [Abstract][Full Text] [Related]